(Circulation. 1995;92:1940-1946.)
© 1995 American Heart Association, Inc.
Articles |
From the Center for Microvascular and Lymphatic Studies, Department of Anesthesiology, The University of TexasHouston Medical School (U.M., S.J.A., D.L.A., K.L.D., G.R.G.); the Department of Veterinary Physiology and Pharmacology, Texas A&M University (G.A.L.), College Station; and the Clinic for Cardiovascular Surgery, University of Cologne (E.R. de V.), Germany.
Correspondence to Steven J. Allen, MD, Department of Anesthesiology, The University of TexasHouston Medical School, 6431 Fannin, MSMB 5.020, Houston, TX 77030. E-mail sallen@anes1.med.uth.tmc.edu.
| Abstract |
|---|
|
|
|---|
Methods and Results In 11 dogs, myocardial water content (MWC) was determined by microgravimetry. Myocardial lymph flow rate was measured after cannulation of the major prenodal cardiac lymphatic. Preload recruitable stroke work (PRSW) was calculated by sonomicrometry and micromanometry. The dogs were placed on normothermic cardiopulmonary bypass (CPB), and BC was delivered at either 80 to 90 mm Hg (BChigh; n=6) or 40 to 50 mm Hg (BClow; n=5) for 1 hour. Coronary sinus lactate and oxygen saturation monitoring demonstrated ischemia avoidance. BC was associated with substantial myocardial lymph flow rate decrease (P<.05) and myocardial edema development in both groups. MWC increased from 76.0±1.9% to 79.2±1.7% (P<.05) after 10 minutes of BChigh and from 75.9±0.6% to 78.9±1.4% (P<.05) after 30 minutes of BClow. PRSW decreased to 63±19% (BChigh) and 69±15% of control (BClow) at 30 minutes after CPB (P<.05). Myocardial lymph flow rate increases of threefold to fourfold that of control (P<.05) resulted in significant myocardial edema reduction associated with PRSW improvement to 71±17% (BChigh) and to 78±11% (BClow) at 2 hours after CPB.
Conclusions We conclude that BC is associated with compromised cardiac function despite ischemia avoidance. This cardiac dysfunction is due to myocardial edema caused by the combination of increased myocardial microvascular fluid filtration and decreased myocardial lymph flow rate during BC.
Key Words: cardioplegia surgery ventricles myocardium edema
| Introduction |
|---|
|
|
|---|
In our previous study,9 conventional cold crystalloid cardioplegic arrest resulted in significantly decreased LV contractility associated with myocardial edema formation. We showed that impaired interstitial fluid removal contributed to this myocardial edema and cardiac dysfunction because we found myocardial lymph flow cessation in the arrested heart.9 We speculated that impaired lymph flow also would occur during cardiac arrest induced by BC, thus enhancing edema formation and LV dysfunction.
Myocardial edema during BC may develop for the following reasons. First, the arrested heart remains in diastole, which prolongs the time available for myocardial microvascular fluid filtration.10 Second, myocardial lymph drainage may be impaired because of the absence of rhythmic cardiac contraction. We previously demonstrated that organized ventricular contraction is the major determinant of myocardial lymphatic function.9 Thus, the combination of increased myocardial microvascular fluid filtration and decreased cardiac lymph drainage may cause myocardial edema and myocardial dysfunction induced by BC.
We hypothesized that BC causes myocardial dysfunction due to myocardial edema. The purpose of the present study was to evaluate the impact of BC on myocardial fluid balance, MWC, and LV function.
Myocardial tissue water content is an important variable in myocardial fluid balance evaluation. Conventional gravimetric methods require too large a sample for sequential determinations. In this study, we modified a microgravimetric technique for MWC quantification that was originally developed for measurement of cerebral edema.11 12 This technique allows determination of changes in MWC over time. Thus, the microgravimetric technique allows time course measurement of both myocardial edema development and resolution.
| Methods |
|---|
|
|
|---|
Subcutaneous needle electrodes were used to monitor the heart rate. We placed fluid-filled catheters into the left femoral artery and vein for mean arterial pressure monitoring and arterial blood sampling and fluid administration, respectively. We inserted a 7F Swan-Ganz thermodilution catheter into the pulmonary artery via the left jugular vein for central venous pressure, PAP, and CO determinations. In nine of the dogs we also advanced a 5F catheter via the right jugular vein into the coronary sinus for coronary sinus blood sampling. We then exposed the right femoral artery for subsequent CPB cannulation. After a median sternotomy, we incised the pericardium and placed a 1/8-in umbilical tape around the inferior vena cava to manipulate cardiac preload. Sonomicrometry crystals (5 MHz, Triton Technology Inc) were placed in the LV subendocardium across the septumfree-wall axis of the LV. A micromanometer-tipped pressure transducer (Millar Instruments Inc) was introduced into the LV cavity through the apex.
In eight dogs, we injected 0.2 to 0.5 mL of Evans blue dye solution (T-1824) into the LV myocardium to facilitate identification of the cardiac lymphatics. We cannulated the prenodal major left cardiac lymph trunk using a heparinized 20-gauge cannula (Medicut, Sherwood Medical Industries) as previously described.10 13 Myocardial lymph flow rate was measured with a calibrated pipette held at heart level. The resistance of this lymph cannula system was 4.11x10-3 mm Hg · min · µL-1.
Hemodynamic Parameters and LV
Function
We connected the pressure monitoring catheters to pressure
transducers (Isotec, Healthdyne Cardiovascular Inc),
and data were recorded on an eight-channel strip-chart
recorder (Grass Instrument Co). We determined CO in duplicate by
injecting 10 mL ice-cold Ringer's solution. LV pressure was
measured with the micromanometer, and LV
septumfree-wall diameter (dLV, in
millimeters) was obtained with a sonomicrometer (Triton
Technology Inc). These data were recorded at a frequency of 200 Hz
(MacLab, World Precision Instruments Inc) and stored on a personal
computer (Macintosh Quadra 700, Apple Computer Inc). If we assume a
spherical shape, the LV volume (VLV [in milliliters]) can
be calculated from the following equation9 :
![]() | (1) |
where rLV is the radius of the LV in centimeters. Replacing rLV with (10-1 · dLV/2) (in millimeters) yields
![]() | (2) |
We recorded LV pressure-volume loops during a 30-second period of inferior vena caval occlusion, and the PRSW (in mm Hg), an index of LV contractility, was calculated as the slope of the relation between LV end-diastolic volume and LV stroke work (SW).14 SW (in mL · mm Hg) was calculated as
![]() | (3) |
where SV is the LV stroke volume, MEP is the LV mean ejection pressure, and EDP is the LV end-diastolic pressure. Ejection onset was defined at 10 ms after the time of +dP/dtmax, and end ejection was defined at the time of -dP/dtmax.14 The unstressed end-diastolic LV volume (V0, in milliliters) was defined as the x intercept of the PRSW relation.14
From the LV pressure signal we derived
, an index of LV isovolumic
relaxation, using the procedure described by Weisfeldt et
al.15 Beginning at -dP/dtmax (end
ejection), plotting dP/dt versus LV pressure yields a line with a slope
of -1/
whose negative reciprocal is
(in
milliseconds).15 This method of
determination does not
depend on the assumption that the LV pressure asymptote equals
zero.15 16
MWC Determination
For MWC determination, we modified a gravimetric technique that
was originally developed for measurement of cerebral
edema.11 12 MWC is determined by specific density
measurement of small myocardial samples using a linear density
gradient. Knowing the specific density of a myocardial sample, the
percent gram of water per gram of tissue can be
calculated.11 12 For preparation of the density gradient,
we used two mixtures of kerosene (specific gravity, 0.773) and
bromobenzene (specific gravity, 1.484). The specific gravities of these
mixtures were adjusted to 0.990 and 1.080,
respectively,11 12 and the density column was generated by
use of a gradient former (model GC-0971, Bethesda Research
Laboratories). We then calibrated the gradient with various
K2SO4 solutions having known specific gravities
of 1.079, 1.072, 1.067, 1.044, 1.035, 1.031, and 1.027. We carefully
placed 10-µL drops of the K2SO4 solutions in
the gradient and recorded the equilibration depth after 1 minute.
We then plotted equilibration depth versus specific gravity and
confirmed the linearity of the gradient by linear least-squares
regression analysis. The mean correlation coefficient (±SD)
was .991±.003; n=11.
To determine the specific gravity of myocardium, we introduced a biopsy forceps (Cordis Corporation) transapically into the LV and collected myocardial samples (6 to 8 mm3). These samples were gently placed into the density gradient, and the equilibration depth was recorded after 1 min. The gram H2O per gram myocardium, or MWC, (%), can be calculated from the following equation11 :
![]() | (4) |
where SGmyo and SGdry are the specific gravities of the myocardial tissue sample and of dry myocardium, respectively. At the end of the experiment, a final myocardial tissue density measurement was performed. We then euthanatized the dog with intravenous pentothal overdose and saturated potassium chloride and rapidly excised the heart. Both ventricles were then weighed, after which they were stored in an oven and dried to a constant weight at 60°C. We calculated SGdry from the following equation11 :
![]() | (5) |
where W and D are wet and dry weights of both ventricles, respectively. We assumed that SGdry did not change over the experimental period. All MWC measurements were performed at least in duplicate.
To test for myocardial vascular volume changes associated with cardiac paralysis, we additionally measured MWC after euthanasia with potassium in five dogs. We found no difference in MWC before versus after cardiac arrest (-0.1±0.2%; P=.92).
CPB and Continuous Warm Blood Cardioplegia
After preparation, heparin (300 IU/kg) was given
intravenously for systemic anticoagulation. Additional
doses of 75 IU/kg heparin were administered every 60 minutes throughout
the experiment. We introduced a 16F arterial perfusion
cannula into the prepared right femoral artery. A two-stage (34F
and 38F) venous cannula (model TAC2, DLP Inc) was placed into the right
atrium and inferior vena cava. The LV was vented with a 12F
catheter inserted via the left atrium. CPB was performed with three
roller pumps for extracorporeal circulation, LV drainage, and suction,
respectively. We primed the extracorporeal circuit and the membrane
oxygenator (Capiox 320, Terumo Corporation) with 800 mL of Ringer's
lactated solution and 1000 IU of heparin. A rectal temperature probe
was placed, and the body temperature was maintained at 37°C during
extracorporeal circulation with a heat exchanger. We maintained CPB
flow between 70 and 90 mL/kg per minute and systemic perfusion pressure
between 50 and 80 mm Hg.
We prepared warm (37°C) BC using a commercially available system
(Sorin Biomedical Inc) that was connected to a heat exchanger. Four
parts oxygenated CPB circuit blood was mixed with one part
crystalloid cardioplegia (Plegisol, Abbott Labs) containing either 130
or 26 mmol/L K+.1 2 Both crystalloid
cardioplegias were connected to a Y tube leading to
the mixing system. This facilitated switching from high to low
K+ concentration. Since arterial K+
concentration was between 3.5 and 5.5 mmol/L, the resulting
K+ concentrations in the 4:1 BC mixtures were
29
to 30 mmol/L in the high-K+ BC and
8 to 10 mmol/L in the
low-K+ BC, respectively.2 We then placed an
aortic root cannula with pressure monitoring line (model 23009, DLP
Inc) into the ascending aorta. After aortic cross-clamping, we
initially delivered high-K+ BC into the aortic root. As
soon as cardiac arrest was achieved, we switched to low-K+
BC and continuously infused low-K+ BC throughout the
60-minute cardiac arrest period unless myocardial electrical activity
necessitated temporary return to high-K+ BC. We delivered
BC at an aortic root pressure of 80 to 90 mm Hg in six dogs (high BC
pressure group) and at 40 to 50 mm Hg in five dogs (low BC pressure
group). To avoid systemic hyperkalemia during the
60-minute period of BC infusion, we administered fuorsemide and/or
glucose-insulin infusion if arterial K+
concentration exceeded 5.5 mmol/L.
Experimental Protocol
After instrumentation, we recorded baseline measurements of
CO, mean arterial pressure, PAP, central venous pressure,
LV pressure-volume loops, and myocardial lymph flow rate. Two
myocardial samples for MWC determination were collected as described
above. Arterial, BC, and coronary sinus plasma
samples were frozen at -20°C for later lactate determination by use
of an enzymatic test (Sigma Diagnostics). We placed the dog
on CPB and initiated cardiac arrest by BC perfusion as described above.
We measured all variables at 10, 30, and 50 minutes during BC
administration (10'BC, 30'BC, and 50'BC, respectively). After 60
minutes of cardiac arrest we stopped BC, removed the aortic
cross-clamp, and weaned the dog from CPB. At 30 and 120 minutes
after separation from CPB (30'p.CPB and 120'p.CPB, respectively) we
repeated all measurements.
To determine the effect of crystalloid CPB priming-induced hemodilution on MWC, we sampled myocardial biopsies at 15 to 20 minutes after CPB initiation and before aortic cross-clamping in five dogs.
Statistical Analysis
All data presented in the text and tables are mean±SD.
Data presented in figures are mean±SEM. We examined the time
courses of each measured parameter using ANOVA for repeated
measures and the F test. Post hoc comparisons were performed
with Student's t test, with a Bonferroni correction for
multiple comparisons. A value of P<.05 was considered
significant.
| Results |
|---|
|
|
|---|
|
|
Sinus rhythm resumed spontaneously in all 11 dogs after cross-clamp
removal, and no dog required positive inotropic support for weaning
from CPB. Tables 3
and 4
show all
hemodynamic variables, LV function data, and
arterial hematocrit concentrations for both groups.
|
|
Compared with baseline, LV contractility as measured by
PRSW was significantly decreased at 30 minutes after CPB in both
groups. At 2 h after CPB, PRSW was still significantly lower compared
with baseline; however, there was a trend for improved
contractility compared with 30 minutes after CPB in
both groups (P=.27 and P=.24, respectively). The
time constant of isovolumic relaxation,
, remained unchanged
after CPB. Compared with the low BC pressure group,
arterial hematocrit was significantly lower at 30'p.CPB and
at 120'p.CPB due to the larger amounts of crystalloid
cardioplegia administered in the high BC pressure group. For all the
other variables, there were no significant differences between
30'p.CPB and 120'p.CPB.
Fig 1
shows the changes in MWC induced by BC. In both
groups, significant edema formed after only 10 min of BC perfusion and
remained on the same level until 30'p.CPB. However, 2 hours after
separation from CPB, part of the myocardial edema was resolved.
Although MWC at 120'p.CPB was still higher compared with baseline in
both groups, there was a significant decrease from 30'p.CPB to
120'p.CPB in the high BC pressure group and from 50'BC to 120'p.CPB in
the low BC pressure group. There was no significant difference between
the time courses of MWC for both groups.
|
Fig 2
demonstrates the impact of BC on myocardial lymph
drainage. Compared with baseline, myocardial lymph flow rate decreased
significantly to <30% during BC and increased to threefold to
fourfold that of control after separation from CPB in both groups.
|
| Discussion |
|---|
|
|
|---|
Fluid movement out of the coronary microvascular exchange vessels is most likely enhanced during BC for the following reason. Diastole is the phase during which perfusion and filtration occur.10 As the arrested heart remains in a continuous diastolic state, time for filtration is increased. Thus, the time-dependent filtration coefficient, which represents water permeability,17 is increased during diastolic arrest because the entire "cardiac cycle" is available for filtration in the absence of systole. Assuming that systole represents about one third of the cardiac cycle,18 the filtration coefficient should be at least 1.5 times higher in the arrested heart compared with the normal beating heart.
In the normal beating heart, increased microvascular filtration causes
increased myocardial lymph flow rate, which is regarded as an important
"anti-edema safety factor".10 13 17 19 20 During
BC, however, we observed significant reduction of myocardial lymph flow
rate (Fig 2
). This is in agreement with our previous work in which we
demonstrated in a hypothermic cardioplegia model that organized
ventricular contraction is the major determinant of
myocardial lymph propulsion.9 Thus, the impaired cardiac
lymph drainage due to the lack of rhythmic cardiac contraction and
relaxation in combination with the increased microvascular filtration
in the arrested heart causes myocardial fluid accumulation during BC.
This is supported by Weng et al,21 who found that repeated
blood perfusion of arrested hearts resulted in progressive heart weight
increases.
Myocardial Fluid Balance During BC
Higher BC perfusion pressure most likely results in increased
myocardial capillary pressure, thus increasing microvascular filtration
rate. We chose BC pressures of 40 to 50 and 80 to 90 mm Hg to cover
the range of clinically and experimentally applied BC
techniques.1 2 5 7 8 21 22 The myocardial edema
accumulation rate was not significantly different between the two
groups, although edema tended to accumulate more slowly in the hearts
perfused at 40 to 50 mm Hg BC pressure (Fig 1
). Since myocardial lymph
flow was similar in both groups, fluid filtration must have been lower
in the low BC pressure group at least during the first 10 minutes of
BC.
From our data, we can determine the proportion of excess myocardial
water due to increased microvascular filtration compared with that
caused by decreased lymph flow. On the basis of myocardial wet and dry
weights measured at the end of the experiments, we calculated that the
observed MWC increase during the first 10 minutes of BC
represents about 18 and 10 mL of additional myocardial water in
the high and low BC pressure groups, respectively. Assuming that our
measured myocardial lymph flow rate approximates 85% of the total
cardiac lymph flow rate,9 we estimate that decreased
myocardial lymph flow could account for only
1 mL of the excess
fluid that accumulated in both groups during the first 10 minutes of
BC. Thus, the major cause of myocardial fluid accumulation in the
arrested perfused heart must have been an increased microvascular
filtration rate. The magnitude of the increase in filtration rate can
be demonstrated in the following fashion. Under baseline conditions,
microvascular filtration rate equals total myocardial lymph flow rate,
or
0.11 mL · min-1, by the above assumption
concerning the percentage of total myocardial lymph flow we collect
with our lymphatic. Net filtration rate can be estimated to be
1.7
mL · min-1 in the high BC pressure group during the
first 10 minutes of BC [18 mL excess water · (10
min)-1-0.1 mL · min-1 decreased lymph
flow], which is about 15-fold higher than baseline. Even at 50 mm Hg
BC perfusion pressure, net filtration rate was still 10-fold higher
than baseline. This clearly demonstrates the
physiological factor, increased filtration, that
predisposes hearts receiving BC to develop edema.
Surprisingly, we found that myocardial edema did not worsen during the
second 30 minutes of BC despite continuous coronary perfusion
(Fig 1
). Since myocardial lymph flow rate remained low
during the whole BC period (Fig 2
), the absence of further myocardial
fluid accumulation after 30 minutes of BC could be due to decreased
microvascular fluid filtration rate and/or increased
interstitial fluid removal via alternative pathways,
including epicardial transudation. Myocardial microvascular fluid
filtration decreased after 30 minutes of BC, probably by the following
mechanism. Myocardial edema formation during the first 30 minutes of BC
was probably accompanied by a progressive myocardial
interstitial pressure increase. Thus, the hydrostatic
pressure gradient determining the rate at which fluid leaves the
microvascular exchange vessels17 23 most likely decreased
due to myocardial edema, thereby decreasing myocardial fluid
filtration. This is supported by previous work that demonstrated that
myocardial interstitial pressure increased because of
myocardial edema10 13 and that increased myocardial
interstitial pressure was associated with decreased
myocardial microvascular fluid filtration.24
Myocardial Edema Resolution
Total myocardial lymph flow at 120'p.CPB is sufficient to remove
the excess fluid in only 1 hour. However, actual edema resolution rates
were only 20% and 30% per hour in the high and low BC pressure
groups, respectively. The most likely reason for this discrepancy is
increased microvascular fluid filtration owing to increased
microvascular permeability. This is supported by several studies that
demonstrated CPB-induced activation of numerous mediators that are
capable of producing increased vascular permeability.25 26 27
Thus, myocardial lymph flow data alone overestimate edema resolution
rate because the observed myocardial lymph flow increase after CPB
probably reflects the combination of myocardial edema resolution and
increased microvascular fluid filtration. Nevertheless, we found that
increased myocardial lymph flow was associated with significant MWC
reduction at 2 hours after separation from CPB. This demonstrates the
important role of cardiac lymph drainage for myocardial edema
resolution.
Impact of Myocardial Edema on LV Function
The impact of myocardial edema on LV function is demonstrated in
Fig 3
. We found a direct inverse relation between MWC
and LV contractility as measured by PRSW. Each
percentage increase in MWC was associated with an 11%
contractility decrease. As shown in Fig 3
, LV
contractility was depressed by
35% at 30 minutes
after CPB, but the improvement 90 minutes later was associated with
significant myocardial edema resolution (Fig 1
). This is in agreement
with other studies that demonstrate the direct impact of myocardial
edema on LV function. Laine and Allen13 showed a 30%
decrease in cardiac reserve in dogs with myocardial edema similar to
that found in the present study. More specifically, Davis et
al28 produced LV edema in an acute dog model and showed
that edema leads to significant LV dysfunction similar to that found in
the present study.
|
Although several investigators have demonstrated that myocardial edema is associated with cardiac dysfunction,9 13 28 29 30 the mechanisms by which myocardial edema compromises myocardial function are not completely understood. Edema could cause cardiac dysfunction by a biomechanical effect. Excess myocardial fluid has been shown to increase myocardial stiffness, thus decreasing LV compliance.21 31 The impaired LV compliance combined with the viscous effects of moving excess interstitial water could compromise the efficiency of myocardial contraction. This mechanism is supported by investigators who demonstrated increased myocardial energy requirements associated with edema.32 33 Furthermore, interstitial fluid accumulation expands the myocardial interstitium, increasing oxygen diffusion distances between capillaries and myocytes. This is particularly important in the heart because it operates at near-maximum oxygen extraction. Thus, interstitial myocardial fluid accumulation could cause decreased contractility by inducing myocyte ischemia.34
Our data show that myocardial edema resolution at 120'p.CPB (Fig 1
) was
associated with a further increase in myocardial lymph flow rate
compared with 30'p.CPB (Fig 2
). The only possible explanations for this
increased lymph flow are a more increased filtration rate or
improved cardiac lymphatic drainage. A more increased filtration
rate seems to be unlikely because MWC decreased. We believe that the
improved LV contractility at 120'p.CPB (Fig 3
) caused
the observed myocardial lymph flow increase. This emphasizes the
importance of regular myocardial contraction for sufficient cardiac
lymphatic function, as demonstrated in our previous
work.9
BC Versus Standard Hypothermic Cardioplegia
In our previous study of cold (4°C) crystalloid cardioplegic
arrest, MWC increased to 78.5% at 1 hour after CPB,9
which is similar to the degree of edema we found with BC at 30 minutes
after CPB. In contrast to BC, cold crystalloid cardioplegia resulted in
both impaired isovolumic relaxation, as indicated by
prolongation,
and LV dilatation, as indicated by V0
increase.9 In Fig 4
, the low BC pressure
group is compared with the conventional crystalloid cardioplegia group.
In contrast to the BC group, which showed contractility
recovery associated with edema resolution from 30 to 120 minutes after
CPB, myocardial edema and depressed contractility
persisted 1 hour after CPB in the crystalloid cardioplegia group. This
suggests that myocardial protection using BC is superior to
conventional crystalloid cardioplegia.
|
In conclusion, the results of our study demonstrate that fluid movement out of the myocardial capillaries into the interstitium is enhanced during BC. Continuous perfusion of the arrested heart resulted in myocardial edema development that was directly associated with compromised LV function. How could edema development in the arrested perfused heart be minimized? Addition of osmotic or oncotic active substances such as mannitol or albumin to the blood cardioplegia does not appear to reduce the microvascular filtration to a rate sufficient to prevent edema.21 30 This is most likely due to the myocardial microvascular exchange barrier's large surface area,35 large pores,36 37 and high protein permeability.10 37 Reduction of BC perfusion pressure below 40 mm Hg may reduce microvascular filtration and limit edema formation but risk ischemia. The ideal BC perfusion pressure that minimizes microvascular fluid filtration and simultaneously ensures homogeneous myocardial perfusion to prevent ischemia has not been determined. Further improvement of myocardial protection regimens will require inclusion of myocardial fluid balance principles.
| Selected Abbreviations and Acronyms |
|---|
|
| Acknowledgments |
|---|
| Footnotes |
|---|
Received February 23, 1995; revision received March 29, 1995; accepted April 16, 1995.
| References |
|---|
|
|
|---|
2. Yau TM, Weisel RD, Mickle DAG, Ivanov J, Mohabeer MK, Tumiati L, Carson S, Liechtenstein SV. Optimal delivery of blood cardioplegia. Circulation. 1991;84(suppl III):III-380-III-388.
3.
Buckberg GD. Normothermic blood
cardioplegia: alternative or adjunct? J Thorac
Cardiovasc Surg. 1994;107:860-867.
4. Salerno TA, Houck JP, Barrozo AM, Panos A, Christakis GT, Abel JG, Liechtenstein SV. Retrograde continuous warm blood cardioplegia: a new concept in myocardial protection. Ann Thorac Surg. 1991;51:245-247. [Abstract]
5. Ko W, Zelano J, Isom OW, Krieger KH. The effects of warm versus cold blood cardioplegia on endothelial function, myocardial function, and energetics. Circulation. 1993;88(pt 2):II-359-II-365.
6. Lajos TZ, Espersen CC, Lajos PS, Fiedler RC, Bergsland J, Joyce LT. Comparison of cold versus warm cardioplegia: crystalloid antegrade or retrograde blood? Circulation. 1993;88(pt 2):II-344-II-349.
7. Matsuura H, Lazar HL, Yang X, Rivers S, Treanor P, Bernard S, Shemin RJ. Warm versus cold blood cardioplegiais there a difference? J Thorac Cardiovasc Surg. 1993;105:45-51. [Abstract]
8. Misare BD, Krukenkamp IB, Lazer ZP, Levitsky SL. Recovery of postischemic contractile function is depressed by antegrade warm continuous blood cardioplegia. J Thorac Cardiovasc Surg. 1993;105:37-44. [Abstract]
9.
Mehlhorn U, Davis KL, Burke EJ, Adams D, Laine GA,
Allen SJ. Impact of cardiopulmonary bypass and
cardioplegic arrest on myocardial lymphatic function. Am
J Physiol. 1995;268:H178-H183.
10. Laine GA, Granger HJ. Microvascular, interstitial, and lymphatic interactions in the normal heart. Am J Physiol. 1985;249:H834-H842.
11. Marmarou A, Poli W, Shulman K, Bhagavan H. A simple gravimetric technique for measurement of cerebral edema. J Neurosurg. 1978;49:530-537. [Medline] [Order article via Infotrieve]
12. Shigeno T, Brock M, Shigeno S, Fritschka E, Cervos-Navarro J. The determination of brain water content: microgravimetry versus drying-weighing method. J Neurosurg. 1982;57:99-107. [Medline] [Order article via Infotrieve]
13.
Laine GA, Allen SJ. Left ventricular
myocardial edema: lymph flow, interstitial fibrosis, and
cardiac function. Circ Res. 1991;68:1713-1721.
14.
Glower DD, Spratt JA, Snow ND, Kabas JS, Davis JW,
Olsen CO, Tyson GS, Sabiston DC, Rankin JS. Linearity of the
Frank-Starling relationship in the intact heart: the concept of preload
recruitable stroke work. Circulation. 1985;71:994-1009.
15. Weisfeldt ML, Weiss JL, Frederiksen JT, Yin FCP. Quantification of incomplete left ventricular relaxation: relationship to the time constant for isovolumic pressure fall. Eur Heart J. 1980;1:119-129.
16. Beattie C, Humphrey LS, Maruschak G. Determination of decay constants from time-varying pressure data. Anesthesiology. 1989;70:159-160. [Medline] [Order article via Infotrieve]
17. Allen SJ. The pathophysiology of myocardial edema: principles of myocardial fluid balance. Curr Opin Anesthesiol. 1994;7:12-17.
18. Braunwald E, Sonnenblick EH, Ross J Jr. Mechanisms of cardiac contraction and relaxation. In: Braunwald E, ed. Heart Disease. 4th ed. Philadelphia, Pa: WB Saunders Co; 1992:351-392.
19.
Laine GA. Microvascular changes in the heart
during chronic arterial hypertension.
Circ Res. 1988;62:953-960.
20. Mehlhorn U, Davis KL, Laine GA, Allen SJ. Myocardial microvascular filtration is directly related to arterial blood pressure in anesthetized dogs. FASEB J. 1994;8:A1050. Abstract.
21. Weng ZC, Nicolosi AC, Detwiler PW, Hsu DT, Schierman SW, Goldstein AH, Spotnitz HM. Effects of crystalloid, blood, and University of Wisconsin perfusates on weight, water content, and left ventricular compliance in an edema-prone, isolated heart model. J Thorac Cardiovasc Surg. 1992;103:504-513. [Abstract]
22. Buckberg GD, Brazier JR, Nelson RL, Goldstein SM, McConnell DH, Cooper N. Studies of the effects of hypothermia on regional myocardial blood flow and metabolism during cardiopulmonary bypass, 1: the adequately perfused beating, fibrillating, and arrested heart. J Thorac Cardiovasc Surg. 1977;73:87-94. [Abstract]
23. Starling EH. On the absorption of fluids from the connective tissue spaces. J Physiol (Lond). 1896;19:312-326.
24. Laine GA, Williams JP, Allen SJ, Gabel JC, Drake RE. Regulation of transmicrovascular fluid and protein flux by interstitial fluid pressure. Fed Proc. 1987;46:1532. Abstract.
25. Chenowith DE, Cooper SW, Huli TE, Steward RW, Blackstone EH, Kirklin JW. Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins. N Engl J Med. 1981;304:497-503. [Abstract]
26. Hammerschmidt DE, Stroncek DF, Bowers TK, Lammi-Keefe CJ, Kurth DM, Ozalins A, Nicoloff DM, Lillihei RC, Craddock PR, Jacobs HS. Complement activation and neutropenia occurring during cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1981;81:370-377. [Abstract]
27.
Dauber IM, Parsons PE, Welsh CH, Giclas PC, Whitman
GJR, Wheeler GS, Horwitz LD, Weil JV. Peripheral
bypass-induced pulmonary and coronary vascular
injury. Circulation. 1993;88:726-735.
28.
Davis KL, Mehlhorn U, Laine GA, Allen SJ.
Myocardial edema, left ventricular function, and
pulmonary hypertension. J Appl
Physiol. 1995;78:132-137.
29. Foglia RP, Steed DL, Follete DM, DeLand E, Buckberg GD. Iatrogenic myocardial edema with potassium cardioplegia. J Thorac Cardiovasc Surg. 1979;78:217-222. [Abstract]
30. Goto R, Tearle H, Steward DJ, Ashmore PG. Myocardial edema and ventricular function after cardioplegia with added mannitol. Can J Anaesth. 1991;38:7-14. [Medline] [Order article via Infotrieve]
31. Pogatsa G, Dubecz E, Gabor G. The role of myocardial edema in left ventricular diastolic stiffness. Basic Res Cardiol. 1976;71:263-269. [Medline] [Order article via Infotrieve]
32. Kahles H, Mezger VA, Hellige G, Spieckermann PG, Bretschneider HJ. The influence of myocardial edema formation on the energy consumption of the heart during aerobiosis and hypoxia. Basic Res Cardiol. 1982;77:158-169. [Medline] [Order article via Infotrieve]
33. Laine GA, Allen SJ. Increased cardiac energy consumption accompanies myocardial interstitial edema. FASEB J. 1992;6:2038. Abstract.
34. Ziegler WH, Goresky CA. Transcapillary exchange in the working left ventricle of the dog. Circ Res. 1971;29:191-207.
35. Wearn JT. The extent of the capillary bed of the heart. J Exp Med. 1928;47:273-291. [Abstract]
36. Bassingthwaighte JB, Yipintsoi T, Grabowski EF. Myocardial capillary permeability: hydrophilic solutes penetrate 100 Å intercellular clefts. Bibl Anat. 1975;13:24-27. [Medline] [Order article via Infotrieve]
37.
Pilati CF. Macromolecular transport in canine
coronary microvasculature. Am J Physiol. 1990;258:H748-H753.
This article has been cited by other articles:
![]() |
F. Eberhardt, M. Heringlake, M. S. Massalme, A. Dyllus, M. Misfeld, H.-H. Sievers, U. K.H. Wiegand, and T. Hanke The effect of biventricular pacing after coronary artery bypass grafting: A prospective randomized trial of different pacing modes in patients with reduced left ventricular function. J. Thorac. Cardiovasc. Surg., June 1, 2009; 137(6): 1461 - 1467. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Egan, T. L. Butler, A. D. Cole, A. Aharonyan, D. Baines, N. Street, M. Navaratnam, O. Biecker, C. Zazulak, C. G. Au, et al. Myocardial ischemia is more important than the effects of cardiopulmonary bypass on myocardial water handling and postoperative dysfunction: A pediatric animal model. J. Thorac. Cardiovasc. Surg., November 1, 2008; 136(5): 1265 - 1273.e2. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kotani, K. Ishino, S. Osaki, O. Honjo, T. Suezawa, K. Kanki, C. Yutani, and S. Sano Efficacy of MCI-186, a free-radical scavenger and antioxidant, for resuscitation of nonbeating donor hearts J. Thorac. Cardiovasc. Surg., June 1, 2007; 133(6): 1626 - 1632. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Osaki, K. Ishino, Y. Kotani, O. Honjo, T. Suezawa, K. Kanki, and S. Sano Resuscitation of Non-Beating Donor Hearts Using Continuous Myocardial Perfusion: The Importance of Controlled Initial Reperfusion Ann. Thorac. Surg., June 1, 2006; 81(6): 2167 - 2171. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. M. Fischer, C. S. Cox Jr, S. J. Allen, R. H. Stewart, U. Mehlhorn, and G. A. Laine The antioxidant N-acetylcysteine preserves myocardial function and diminishes oxidative stress after cardioplegic arrest J. Thorac. Cardiovasc. Surg., November 1, 2003; 126(5): 1483 - 1488. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Ngaage Off-pump coronary artery bypass grafting: the myth, the logic and the science Eur. J. Cardiothorac. Surg., October 1, 2003; 24(4): 557 - 570. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Steensrud, D. Nordhaug, O.P. Elvenes, C. Korvald, and D.G. Sorlie Superior myocardial protection with nicorandil cardioplegia Eur. J. Cardiothorac. Surg., May 1, 2003; 23(5): 670 - 677. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Mehlhorn, H. J. Geissler, G. A. Laine, and S. J. Allen Myocardial fluid balance Eur. J. Cardiothorac. Surg., December 1, 2001; 20(6): 1220 - 1230. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Korvald, O. P. Elvenes, T. Myrmel, and D. G. Sorlie Cardiac dysfunction and inefficiency after substrate-enriched warm blood cardioplegia Eur. J. Cardiothorac. Surg., September 1, 2001; 20(3): 555 - 564. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Mehlhorn, H. J. Geissler, G. A. Laine, and S. J. Allen Role of the cardiac lymph system in myocardial fluid balance Eur. J. Cardiothorac. Surg., August 1, 2001; 20(2): 424 - 425. [Full Text] [PDF] |
||||
![]() |
A. B. Ericsson, S. Takeshima, and J. Vaage Warm or cold continuous blood cardioplegia provides similar myocardial protection Ann. Thorac. Surg., August 1, 1999; 68(2): 454 - 459. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Kuhn-Regnier, E. Natour, S. Dhein, O. Dapunt, H. J. Geissler, K. LaRose, C. Gorg, and U. Mehlhorn Beta-blockade versus Buckberg blood-cardioplegia in coronary bypass operation Eur. J. Cardiothorac. Surg., January 1, 1999; 15(1): 67 - 74. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Warters, S. J. Allen, K. L. Davis, H. J. Geissler, I. Bischoff, E. Mutschler, and U. Mehlhorn {beta}-Blockade as an Alternative to Cardioplegic Arrest During Cardiopulmonary Bypass Ann. Thorac. Surg., April 1, 1998; 65(4): 961 - 966. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. Ericsson, S. Takeshima, and J. Vaage Simultaneous Antegrade And Retrograde Delivery Of Continuous Warm Blood Cardioplegia After Global Ischemia J. Thorac. Cardiovasc. Surg., March 1, 1998; 115(3): 716 - 722. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Miyamoto, D. E. McClure, E. R. Schertel, P. J. Andrews, G. A. Jones, J. W. Pratt, P. Ross, and P. D. Myerowitz Effects of hypoproteinemia-induced myocardial edema on left ventricular function Am J Physiol Heart Circ Physiol, March 1, 1998; 274(3): H937 - H944. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.L Ludwig, E.R Schertel, J.W Pratt, D.E McClure, A.J Ying, C.F Heck, and P.D Myerowitz Impairment of left ventricular function by acute cardiac lymphatic obstruction Cardiovasc Res, January 1, 1997; 33(1): 164 - 171. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Mehlhorn, S. J. Allen, D. L. Adams, K. L. Davis, G. R. Gogola, and R. D. Warters Cardiac Surgical Conditions Induced by {beta}-Blockade: Effect on Myocardial Fluid Balance Ann. Thorac. Surg., July 1, 1996; 62(1): 143 - 150. [Abstract] [Full Text] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |